Your browser doesn't support javascript.
loading
Protective measures for patients with advanced cancer during the Sars-CoV-2 pandemic: Quo vadis?
Ivanyi, P; Park-Simon, T; Christiansen, H; Gutzmer, R; Vogel, A; Heuser, M; Golpon, H; Hillemanns, P; Haier, J.
Afiliação
  • Ivanyi P; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, 6860, Carl-Neuberg Strasse 1, 30625, Hannover, OE, Germany. Ivanyi.philipp@mh-hannover.de.
  • Park-Simon T; Comprehensive Cancer Center Niedersachsen (CCC-N), Hannover Medical School, Hannover, Germany. Ivanyi.philipp@mh-hannover.de.
  • Christiansen H; Immuncooperative Oncology Group (ICOG) of CCC-N, Hannover Medical School, Hannover, Germany. Ivanyi.philipp@mh-hannover.de.
  • Gutzmer R; Department of Gynecology and Obsterics, Hannover Medical School, Hannover, Germany.
  • Vogel A; Comprehensive Cancer Center Niedersachsen (CCC-N), Hannover Medical School, Hannover, Germany.
  • Heuser M; Department of Radiotherapy and Special Oncology, Hannover Medical School, Hannover, Germany.
  • Golpon H; Comprehensive Cancer Center Niedersachsen (CCC-N), Hannover Medical School, Hannover, Germany.
  • Hillemanns P; Department of Dermatology and Allergy, Skin Cancer Center Hannover, Hannover Medical School, Hannover, Germany.
  • Haier J; Comprehensive Cancer Center Niedersachsen (CCC-N), Hannover Medical School, Hannover, Germany.
Clin Exp Metastasis ; 38(3): 257-261, 2021 06.
Article em En | MEDLINE | ID: mdl-33759009

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prevalence_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prevalence_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article